Beta-blocker Administration for Cardiomyocyte Division — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Weill Cornell Medicine, New York, New York Children's Hospital of Philadelphia, Philadelphia, Pennsylvania Upmc Children'S Hospital of Pittsburgh, Pittsburgh, Pennsylvania Age range
30 Days – 60 Days
Last updated November 2025